loader
Please Wait
Applying Filters...

Seqens Seqens

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    List of All Manufacturers & Suppliers for 70182 Licensing, EU CTD Dossiers, Marketing Authorizations, Finished Dosage Formulations listed on PharmaCompass.com

    Client Virtual Booth
    Menu

    Chartwell Pharmaceuticals llc

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    DEVELOPMENTS

    DOSSIERs // Finished Dosage Forms

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Minakem offers CDMO services for API & HPAPI, generics, regulatory expertise, track record performance & FDA & GMP certifications.

    Send me more info on How To Grow My Business Digitally?

    Left Arrow
    Right Arrow
    Filters Filter
    Cross PopUp
    FILTER :

    filter

    01 HYDROCHLOROTHIAZIDE; METHYLDOPA (1)

    filter

    01 CHARTWELL RX (1)

    filter

    01 TABLET;ORAL (1)

    filter

    01 15MG;250MG (1)

    filter

    01 USA (1)

    ListList of Suppliers
    refresh Reset Filter
    refresh Reset Filter
    product-page Supplier Virtual Booth
    price-trend Ask Us
    Contact Supplier
    • FDA
    Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Hydrochlorothiazide; Methyldopa

    PDF Supplier PDF
    URL Supplier Web Content
    TABLET;ORAL
    15MG;250MG
    METHYLDOPA AND HYDROCH...
    USA
    70182
    1986-01-15
    DISCN
    ASK
    US
    PHARMACOMPASS
    Upload
    your Marketing & Sales content

    Looking for CTD TGA MCC DOSSIER APPLICATION 70182

    Looking for CTD TGA MCC DOSSIER APPLICATION 70182 1

    19

    Chartwell Pharmaceuticals llc, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA.

    One of their notable products is HYDROCHLOROTHIAZIDE; METHYLDOPA, with a corresponding application number 70182 and regulatory information .

    proudly manufactured in the

    approval since 1986-01-15

    Chartwell Pharmaceuticals llc's METHYLDOPA AND HYDROCHLOROTHIAZIDE TABLET;ORAL, medication with 15MG;250MG of HYDROCHLOROTHIAZIDE; METHYLDOPA.

    Post Enquiry
    POST ENQUIRY